search button
Open Access

[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer

  • Authors:
    • Yu-Hua Xu
    • Jian-Ren Tu
    • Tian-Tian Zhao
    • Shi-Guang Xie
    • Sheng-Bo Tang

  • View Affiliations

  • Published online on: January 14, 2019     https://doi.org/10.3892/ijo.2019.4686
  • Pages: 340-340

  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Int J Oncol 54: [Related article:] 295-305, 2019; DOI: 10.3892/ijo.2018.4629

After the publication of the article, the authors have realized that the affiliation presented for the joint co-author listed on the paper (Jian-Ren Tu) was incorrect. The correct author list (and affiliations) should therefore have been published as follows:

YU-HUA XU1,*, JIAN-REN TU2,*, TIAN-TIAN ZHAO3, SHI-GUANG XIE3 and SHENG-BO TANG4

1Department of Cardiovascular Medicine, Jiangxi Chest Hospital, Nanchang, Jiangxi 330006; 2Department of Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029; Departments of 3Respiratory Medicine and 4Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China

*Contributed equally

The authors apologize for their oversight, and for any inconvenience that this has caused.

Related Articles

Journal Cover

July-2019
Volume 55 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 9.6
  • CiteScore Rank: Q1: #66/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.88
  • SCImago Journal Rank (SJR): 1.099
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Xu Y, Tu J, Zhao T, Xie S and Tang S: [Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer. Int J Oncol 55: 340-340, 2019.
APA
Xu, Y., Tu, J., Zhao, T., Xie, S., & Tang, S. (2019). [Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer. International Journal of Oncology, 55, 340-340. https://doi.org/10.3892/ijo.2019.4686
MLA
Xu, Y., Tu, J., Zhao, T., Xie, S., Tang, S."[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer". International Journal of Oncology 55.1 (2019): 340-340.
Chicago
Xu, Y., Tu, J., Zhao, T., Xie, S., Tang, S."[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer". International Journal of Oncology 55, no. 1 (2019): 340-340. https://doi.org/10.3892/ijo.2019.4686